Patient info Open main menu

Posaconazole SP - patient leaflet, side effects, dosage

Contains active substance :

Dostupné balení:

Patient leaflet - Posaconazole SP

5. HOW TO STORE POSACONAZOL


Do not freeze.


Do not use Posaconazole SP after the expiry date which is stated on the label. The expiry date refers to the last day of that month.


If you have any suspensi not use this medicine.


Medicines should no dispose of medicines



a bottle more than four weeks after it was first opened, you should turn the bottle containing any left over suspension to your pharmacist.


osed of via wastewater or household waste. Ask your pharmacist how to o longer required. These measures will help to protect the environment.


Wha

6. FU

INFORMATION


nazole SP contains



The active substance in Posaconazole SP oral suspension is posaconazole. Each millilitre of oral suspension contains 40 milligrams of posaconazole.

The other ingredients in the suspension are polysorbate 80, simeticone, sodium benzoate (E211), sodium citrate dihydrate, citric acid monohydrate, glycerol, xanthan gum, liquid glucose, titanium dioxide (E171), artificial cherry flavour containing benzyl alcohol and propylene glycol, and purified water.

What Posaconazole SP looks like and contents of the pack

representative of the


Posaconazole SP is a white, cherry flavoured, 105 ml oral suspension packaged in amber glass bottles. A measuring spoon is provided with each bottle for measuring 2.5 and 5 ml doses of the oral suspension.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

SP Europe

Rue de Stalle, 73

B-1180 Bruxelles

Belgium

Manufacturer:

SP S.A.

2, rue Louis Pasteur

F-14200 Hérouville St Clair

France

For any information about this medicinal product, please contact t Marketing Authorisation Holder:

België/Belgiqu­e/Belgien

Rue de Stalle/Stallestraat 73

B-1180 Bruxelles/Brus­sel/Brüssel

Tél/Tel: + 32-(0)2 370 92 11


Luxe R B-11


Btnrapua

Höct napK Tpeug UeHrtp

Ev.t „H.M.Banuapoß” 53A, em. 2

BG-Co$ua 1407

Ten.: +359 2 806 3030


Česká republika

Na Příkopě 25 CZ-110 00 Praha 1 Tel: +420 221771250


Danmark

Lautrupbjerg 2

DK-2750 Balleru Tlf: + 45–44 39 5


H-1123 Budapest

Tel.: +36 1 457–8500

Malta

168 Christopher Street

MT-VLT02 Valletta Tel: + 356–21 23 21 75


/Luxemburg 73

ruxelles/Brüssel que/Belgien el: + 32-(0)2 370 92 11



Nederland

Maarssenbroeksedijk 4 NL-3542 DN Utrecht

Tel: + 31-(0)800 778 78 78


Deutschland

Thomas-Dehler-Straße 27

D-81737 München

st

EXXáóa


)89 627 31–0 ärvevana tee 9

–11314 Tallinn

el: + 372 654 96 86

Norge

Pb. 398

N-1326 Lysaker

Tlf: + 47 67 16 64 50

Österreich

Am Euro Platz 2

A-1120 Wien

Tel: + 43-(0) 1 813 12 31

Polska

Ayîou An^Tpiou 63 GR-174 55 AXi^oç

TnÀ.: + 30–210 98 97 300

Espana

Km. 36, Ctra. Nacional I

E-28750 San Agustin de Guadalix – Madrid

Tel: + 34–91 848 85 00


France

92 rue Baudin

F-92300 Levallois-Perret

Tél: + 33-(0)1 41 06 35 00

Ireland

Shire Park

Welwyn Garden City

Hertfordshire AL7 1TW

Tel: +44-(0)1 707 363 636

Ísland

Horgatun 2

IS-210 Garôabær

Simi: + 354 535 70 00

Ul. Tasmowa 7

PL-02–677 Warszawa

Tel.: + 48-(0)22 478 41 50

Portugal

Rua Agualva dos Açores 16

P-2735–557 Agualva-Cacém

Tel: +351–21 433 93 00

România

§os. Bucureçti-Ploieçti, nr. 17–21,

Bâneasa Center, et. 8, sector 1

RO-013682 Bucureçti S

Tel. + 40 21 233 35 30


Slovenija

Dunajska 22 SI-1000 Ljubljana

Tel: + 386 01 3001


2) 5920 2712



Slovenska

Strakov

SK-8

Tel: +

Italia

Via fratelli Cervi snc,

Centro Direzionale Milano Due

Palazzo Borromini

I-20090 Segrate (Milano)

Tel: + 39–02 21018.1

Knnpoç

Oôoç Ayîou NiKoÀaou, 8

CY-1055 AeuKffloia

TnÀ: +357–22 757188

/4

United Kingdom

Shire Park

Welwyn Garden City

Hertfordshire AL7 1TW – UK

Tel: + 44-(0)1 707 363 636

Sverige

Box 6185

S-102 33 Stockholm

Tel: + 46-(0)8 522 21 500

2 101868


Latvija

Bauskas 58a –401

Riga, LV-1004

Tel: + 371–7 21

Lietuva

Kçstu LT-08 Tel.

Suomi/Finland

PL 86/PB 86

FIN-02151 Espoo/Esbo

Puh/Tel: + 358-(0)20–7570 300

is leaflet was last approved on


etailed information on this medicine is available on the European Medicines Agency (EMEA) web site:


32